Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Basal Insulin-Fc for treating type 1 diabetes	Basal Insulin-Fc	Type 1 diabetes	Endocrine Nutritional and Metabolic Disorders	2023	View \| Download
AZD3152 for preventing COVID-19	AZD3152	COVID-19	Infectious Disease	2023	View \| Download
Avacincaptad pegol for the treatment of geographic atrophy secondary to age-related macular degeneration	Avacincaptad pegol	Age-related macular degeneration (AMD) , Geographic atrophy	Ophthalmology	2023	View \| Download
Atezolizumab with paclitaxel and carboplatin for previously untreated advanced endometrial cancer	Atezolizumab (Tecentriq; MPDL3280A) , Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin)	Endometrial cancer	Female Reproductive Cancer	2023	View \| Download
Aprocitentan for treating resistant hypertension	Aprocitentan (ACT-132577; AC-080; ACT 13257; Actelion)	Resistant hypertension	Cardiovascular System	2023	View \| Download
Apremilast for treating moderate to severe plaque psoriasis in children and young people	Apremilast (Otezla; CC-10004)	Plaque psoriasis	Dermatology	2023	View \| Download
Apalutamide for treating high-risk, localised or locally advanced prostate cancer	Apalutamide (Erleada; ARN-509)	Prostate cancer	Male Reproductive Cancer	2023	View \| Download
Amivantamab with lazertinib for previously untreated locally advanced or metastatic non-small-cell lung cancer	Amivantamab (JNJ-6372; JNJ-61186372) , Lazertinib	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Alpelisib for treating PIK3CA-related overgrowth spectrum	Alpelisib (BYL719; Piqray)	PIK3CA-related overgrowth spectrum (PROS)	Genetic Disorders	2023	View \| Download
Alectinib adjuvant therapy for ALK-positive non-small cell lung cancer	Alectinib (Alecensa)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download